Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-22-043018
Date:2022-07-20
Issuer: VERVE THERAPEUTICS, INC. (VERV)
Original Submission Date:

Reporting Person:

BELLINGER ANDREW
C/O VERVE THERAPEUTICS, INC.
500 TECHNOLOGY SQUARE, SUITE 901 CAMBRIDGE, MA 02139

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2022-07-20 M 20,000 a $1.39 26,629 direct
COMMON STOCK 2022-07-20 S 20,000 d $34.90 6,629 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 1.39 2022-07-20 deemed execution date M 20,000 (d) 2029-06-24 common stock 20,000 $1.39 1,599 direct
Footnotes
IDfootnote
f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on march 20, 2022.
f2 the option was granted on june 25, 2019 for 21,599 shares. the shares underlying the option vested on may 1, 2020.
WhaleWisdom Logo

Elevate your investments